Evidence map›Paper›PMID 31056655›Full record

Trial reportThe journals of gerontology. Series A, Biological sciences and medical sciences2019

High Flavonoid Cocoa Supplement Ameliorates Plasma Oxidative Stress and Inflammation Levels While Improving Mobility and Quality of Life in Older Subjects: A Double-Blind Randomized Clinical Trial.

Levy Munguia, Ivan Rubio-Gayosso, Israel Ramirez-Sanchez, Alicia Ortiz, Isabel Hidalgo, Cristian Gonzalez, Eduardo Meaney, Francisco Villarreal, Nayelli Najera, Guillermo Ceballos

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The journals of gerontology. Series A, Biological sciences and medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03585868 (Evaluation of the Effects of a COcoa Supplement to Reduce FRailty in the Elderly), which is not on this map. Cited by 39 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03585868 nacompletednot on this map

Evaluation of the Effects of a COcoa Supplement to Reduce FRailty in the Elderly: COFRE a Randomized Clinical Trial

TypeinterventionalSponsorNational Polytechnic Institute, MexicoRan2017 to 2017Enrolled30ConditionsSarcopenia, Frail Elderly SyndromeArmsPlacebo, Flavonoids, No Flavonoids
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Dentistry journal · 2026
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Levy MunguiaSeccion de Estudios de Posgrado e Investigacion, Escuela Superior de Medicina, Mexico.
Ivan Rubio-GayossoSeccion de Estudios de Posgrado e Investigacion, Escuela Superior de Medicina, Mexico.
Israel Ramirez-SanchezSeccion de Estudios de Posgrado e Investigacion, Escuela Superior de Medicina, Mexico.
Alicia OrtizDepartamento de Ingenieria Bioquimica, Escuela Nacional de Ciencias Biologicas, Instituto Politecnico Nacional, Mexico.
Isabel HidalgoSeccion de Estudios de Posgrado e Investigacion, Escuela Superior de Medicina, Mexico.
Cristian GonzalezSeccion de Estudios de Posgrado e Investigacion, Escuela Superior de Medicina, Mexico.
Eduardo MeaneySeccion de Estudios de Posgrado e Investigacion, Escuela Superior de Medicina, Mexico.
Francisco VillarrealDepartment of Medicine, School of Medicine, University of California San Diego, La Jolla.
Nayelli NajeraSeccion de Estudios de Posgrado e Investigacion, Escuela Superior de Medicina, Mexico.
Guillermo CeballosSeccion de Estudios de Posgrado e Investigacion, Escuela Superior de Medicina, Mexico.

Funding

Epicatechin treatment for sarcopeniaR21AG047326 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VILLARREAL, FRANCISCO J · 2015 to 2015
$233k
NIA NIH HHS R21 AG047326
6 · The paper itself

Abstract

backgroundThe age-related decline in mass, strength, and performance of skeletal muscle is associated with loss of independence, falls risk, disability, institutionalization, and death.

methodsTo determine whether a cocoa supplement enriched in flavonoids can improve plasma markers of oxidative stress and inflammation, physical performance and frailty in middle-aged and older subjects, we conducted a two-phase, randomized, double-blind, clinical trial. The initial study included 60 subjects (55- to 70-year-old) allocated into placebo (P), highly alkalinized (no-flavonoid; NF), or flavonoid-rich natural cocoa (F) beverage groups. The follow-up study included 74 older subjects (65- to 90-year-old) randomly distributed into NF or F groups. Subjects were instructed to consume the beverages once/day for up to 12-weeks. A comprehensive (aging relevant) set of end points were assessed, which included mean change in blood plasma metabolic and oxidative stress indicators, in physical performance tests and quality of life (QoL).

resultsIn the initial study, the F group showed improved glycemia, triglyceridemia, High-density lipoprotein cholesterol, Low-density lipoprotein cholesterol, triglyceridemia/HDL index, and oxidative markers. Performance on the Up and Go test, skeletal muscle index, and quality of life also improved. In the follow-up study, F treatment was associated with significant improvements in metabolic, oxidative stress, and inflammatory endpoints and positive effects on physical performance, frailty indicators, and quality of life (F vs. NF group).

conclusionsRegular flavonoids consumption positively affects blood oxidative stress and inflammation end points, cardiometabolic risk markers, physical performance, and quality of life. The sum of such effects may help to mitigate the extent of frailty development in the elderly people.

trial registrationNCT03585868.

Indexed as

BeveragesChocolateDietary SupplementsAgedAged, 80 and overDouble-Blind MethodFemaleFlavonoidsHumansInflammationMaleMiddle AgedMotor ActivityOxidative StressQuality of LifeFlavonoidsFunctional performanceMetabolismPreventative health careSarcopenia

Identifiers

PMID31056655
PMCPMC6748722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.